Vaccine-Related Journal Articles
Hepatitis Prevention Settings
Corrections Harm reduction School programs
Family planning Perinatal STD/HIV clinic
Harm Reduction 2007 Archive 2003-2000
A Peer-Education Intervention to Reduce Injection Risk Behaviors for HIV and Hepatitis C Virus Infection in Young Injection Drug Users
Authors: Garfein RS, Golub ET, Greenberg AE, et al
Source: AIDS, Sep 21, 2007; 21(14):1923-1932
Abstract
Prevalence and Correlates of Hepatitis A among Adult Drug Users: The significance of incarceration and race/ethnicity
Authors: Latimer WW, Moleko AG, Melnikov A, et al
Source: Vaccine, August 13, 2007 [Epub ahead of print]
Abstract
Seroprevalence of Hepatitis C Virus and Hepatitis B Virus among San Francisco Injection Drug Users, 1998 to 2000
Authors: Tseng FC, Obrien, Zhang M, et al
Source: Hepatology July 26, 2007 [Epub ahead of print]
Abstract
Sex, Drugs, and Hepatitis C Virus
Author: Hahn JA
Source: J Infect Dis, June 1, 2007, Vol. 195(11):1556-9
Abstract
Individual and Couple-Level Risk Factors for Hepatitis C Infection among Heterosexual Drug Users: A Multilevel Dyadic Analysis
Authors: McMahon JM, Pouget ER, Tortu S
Source: J Infect Dis, June 1, 2007, Vol. 195(11):1572-81
Abstract
Hepatitis B Infection and Vaccination Among High-Risk Noninjection Drug-Using Women: Baseline data from the UNITY Study
Authors: Koblin BA, Xu G, Lucy , Robertson V, et al
Source: Sex Transm Dis. June 2007 (Epub)
Abstract
Methods to Recruit and Retain a Cohort of Young-Adult Injection Drug Users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT)
Authors: Garfein RS, Swartzendruber A, Ouellet LJ, Kapadia F, et al
Source: Drug Alcohol Depend. June 2007 (Epub)
Abstract
Integrating Hepatitis Prevention Services into a Substance Use Disorder Clinic
Authors: Hagedorn H. Dieperink E. Dingmann D, Durfee J, et al
Source: J Subst Abuse Treat. June 2007;32(4):391-8
Abstract
Benefits and Adverse Effects of Hepatitis C Screening: Early results of a screening program
Authors: Trepka MJ, Zhang G, Leguen F, Obiaja K, et al
Source: J Public Health Manag Pract. May/June, 2007;13(3):263-9
Abstract
Infectivity of Hepatitis C Virus in Plasma after Drying and Storing at Room Temperature
Authors: Kamili S, Krawczynski K, et al
Source: Infect Control Hosp Epidemiol, May 2007, Vol. 28(5):519-24
Abstract
A Systematic Review of Provider Knowledge of Hepatitis C: Is it Enough for a Complex Disease?
Authors: Zickmund SL, Brown KE, Bielefeldt K
Source: Dig Dis Sci. April 4, 2007 Apr 4 [EPub ahead of print]
Abstract
Sexual and Other Noninjection Risks for HBV and HCV Seroconversions Among Noninjecting Heroin Users
Authors: Neaigus A, Gyarmathy VA, Zhao M, Miller M, et al
Source: J Infect Dis. Apr 1, 2007;195(7):1052-61
Abstract
Self Reported Risk Behaviour Among Injecting Drug Users: Self versus assisted questionnaire completion
Authors: White B, Day C, Maher L
Source: AIDS Care, March 2007, Vol. 19(3):441-7
Abstract
Surveillance for Acute Viral Hepatitis--United States, 2005
Authors: Wasley A, Miller JT, Finelli L, Centers for Disease Control and Prevention
Source: MMWR Surveill Summ. March 16, 2007;56(3):1-24
HTML
Trends in Hepatitis B Virus, Hepatitis C Virus, and Human Immunodeficiency Virus Prevalence, Risk Behaviors, and Preventive Measures among Seattle Injection Drug Users Aged 18-30 Years, 1994-2004
Authors: Burt RD, Hagan H, Garfein RS, Sabin K, et al
Source: J Urban Health. Mar 14, 2007; [Epub ahead of print]
Abstract
Hepatitis C Management by Addiction Medicine Physicians: Results from a national survey
Authors: Litwin AH, Kunins HAV, Berg KM, Federman AD, et al
Source: J Subst Abuse Treat. March 2007;20; [Epub ahead of print]
Abstract
Injecting and Sexual Risk Correlates of HBV and HCV Seroprevalence Among New Drug Injectors
Authors: Neaigus A, Gyarmathy V, Miller M, Frajzyngier V, et al
Source: Drug Alcohol Depend Jul 10,;89(2-3):234-243. Epub 2007 Feb 7
Abstract
Convenience is the Key to Hepatitis A and B Vaccination Uptake among Young Adult Injection Drug Users
Authors: Campbell JV, Garfein RS, et al
Source: Drug Alcohol Depend, February 1, 2007
Abstract
Harm Reduction 2006 back to top
Hepatitis B Vaccination Coverage Among Adults --- United States, 2004
Source: MMWR, May 12, 2006, Vol. 55(18):509-511
HTML
Partner Notification for Persons with Chronic Hepatitis B Virus Infection: Use of a Syphilis Model Service
Source: Sexually Transmitted Diseases, May 2006, Vol. 33(5)
Abstract
Overcoming Barriers to Prevention, Care, and Treatment of Hepatitis C in Illicit Drug Users [Review] [131 refs]
Authors: Edlin BR, Kresina TF, Raymond DB, et al
Source: CID April 15, 2006, Vol. 40(5)276-85
Abstract
Harm Reduction 2005 back to top
Hepatitis C Virus Load and Survival Among Injection Drug Users in the United States
Source: Hepatology, December 2005, Vol. 42(6):1261-3
Abstract
Prevalence and Correlates of Hepatitis C Infection Among Users of North America’s First Medically Supervised Safer Injection Facility
Source: Public Health, December 2005, Vol. 119(12):1111-5
Abstract
Tattoos, Incarceration and Hepatitis B and C Among Street-Recruited Injection Drug Users in New Mexico, USA: Update
Source: Epidemiol Infect, December 2005, Vol. 133(6):1146-8
Abstract
Viral Evolution of Hepatitis C in Injection Drug Users
Source: J Viral Hepat, November 2005, Vol. 12(6):574-583
Abstract
Public Health Perspective on Vaccine-Preventable Hepatitis: Integrating Hepatitis A and B Vaccines into Public Health Settings
Source: Am J Med, October 2005, Vol. 118(Suppl 10A):100S-108S
Abstract
Health Disparities Among African-American and Hispanic Drug Injectors—HIV, AIDS, Hepatitis B Virus and Hepatitis C Virus: A Review
Source: AIDS, October 2005, Vol. 19(Suppl 3):S47-S52
Abstract
HIV/Hepatitis C Virus Co-Infection in Drug Users: Risk Behavior and Prevention
Source: AIDS, October 2005, Vol. 19(Suppl 3):S199-S207
Abstract
A Framework for Understanding Factors that Affect Access and Utilization of Treatment for Hepatitis C Virus Infection Among HCV-Mono-Infected and HIV/HCV-Co-Infected Injection Drug Users
Source: Aids, October 2005, Vol. 19(Suppl 3):S179-S189
Abstract
Reductions in Hepatitis C Virus and HIV Infections Among Injecting Drug Users in New York City, 1990-2001
Source: AIDS, October 2005, Vol. 19(Suppl 3):S20-5
Abstract
Psychological and Behavioral Differences among Drug Injector Who Use and Do Not Use Syringe Exchange Programs
Source: AIDS and Behavior, October 20, 2005, EPub
Abstract
Susceptibility to Hepatitis A in Patients with Chronic Liver Disease Due to Hepatitis C Virus Infection: Missed Opportunities for Vaccination
Source: Hepatology, September 2005, Vol. 42(3):688-695
Abstract
Risk Factors for Hepatitis B in an Outbreak of Hepatitis B and D Among Injection Drug Users
Source: Journal of Urban Health, September 2005, Vol. 82(3):468-78
Abstract
High Prevalence of Alcohol Use Among Hepatitis C Virus Antibody Positive Injection Drug Users in Three US Cities
Source: Drug Alcohol Depend, August 26, 2005:Epub
Abstract
Do Supervised Injecting Facilities Attract Higher-Risk Injection Drug Users?
Source: American Journal of Preventive Medicine, August 2005, Vol. 29(2):126-130
Abstract
Update: Syringe Exchange Programs—United States, 2002
Source: MMWR, July 15, 2005, Vol. 54(27):673-676
Abstract
Integrating Care for Hepatitis C Virus (HCV) and Primary Care for HIV for Injection Drug Users Coinfected with HIV and HCV
Source: Clin Infect Dis, July 1, 2005, Vol. 41(Suppl 1):S83-8
Abstract
Approaching Treatment for Hepatitis C Virus Infection in Substance Users
Source: Clin Infect Dis, July 1, 2005, Vol. 41(Suppl 1):S79-S82
Abstract
A Systematic Approach to the Treatment of HIV and Hepatitis C Virus Infection in the Inner City: A Canadian Perspective
Source: Clin Infect Dis, July 1, 2005, Vol. 41(Suppl 1):S73-8
Abstract
Coinfection with HIV and Hepatitis C Virus in Injection Drug Users and Minority Populations
Source: Clin Infect Dis, July 1, 2005, Vol. 41(Suppl 1):S7-S13
Abstract
Medical Management of HIV-Hepatitis C Virus Coinfection in Injection Drug Users
Source: Clin Infect Dis, July 1, 2005, Vol. 41(Suppl 1):S1-S6
Abstract
Management of Hepatitis C Virus in Special Populations: Patient and Treatment Considerations
Source: Clin Gastroenterol Hepatol, April 2005, Vol. 3(4):311-8
Abstract
Being Realistic About Benefits of Supervised Injecting Facilities
Source: The Lancet, March 26, 2005, Vol. 365(9465)
PDF
Circumstances Surrounding the First Injection Experience and their Association with Future Syringe Sharing Behaviors in Young Urban Drug Users
Source: Drug Alcohol Depend. March 7, 2005, Vol.77(3):303-9
Abstract
Adherence to Hepatitis B Virus Vaccination at Syringe Exchange Sites
Source: Journal of Urban Health, March 2005, Vol. 82(1):151-161
Abstract
Effects of an Intensive Street-Level Police Intervention on Syringe Exchange Program Use in Philadelphia, Pa.
Source: American Journal of Public Health, February 2005, Vol. 95(2):233-6
Abstract
Exploring the Role of Needle Selling in a Drug-Using Community in Baltimore, Maryland
Source: J Acquir Immune Defic Syndr, January 1, 2005, Vol. 38(1):57-60
Abstract
Harm Reduction 2004 back to top
Acceptance and Completion of Hepatitis B Vaccination Among Drug Users in New York City
Source: Communicable Disease and Public Health, December 2004, Vol. 7(4):294-300
Abstract
Co-occurring Hepatitis C, Substance Use, and Psychiatric Illness: Treatment Issues and Developing Integrated Models of Care
Source: Journal of Urban Health, December 2004, Vol.81(4):719-734
Abstract
Incidence of Hepatitis C Virus and HIV Among New Injecting Drug Users in London: Prospective Cohort Study
Source: British Medical Journal, November 12, 2004, Eprint 1-2
Abstract
A Comparison of Injection and Non-Injection Methamphetamine-Using HIV Positive Men Who Have Sex with Men
Source: Drug Alcohol Depend, November 11, 2004, Vol. 76(2):203-212
Abstract
Frequent Hepatitis C Virus Superinfection in Injection Drug Users
Source: Journal of Infectious Diseases, October 15, 2004, Vol. 190(8):1396-1403
Abstract
Correlates of Hepatitis C Virus Infections in Homeless Men: A Latent Variable Approach
Source: Drug Alcohol Depend, July 15, 2004, Vol. 75(1):89-95
Abstract
A Syringe Prescription Program to Prevent Infectious Disease and Improve Health of Injection Drug Users
Source: J Urban Health, March 2004, Vol. 81(1):122-134
Abstract
Hepatitis C Incidence--A Comparison Between Injection and Noninjection Drug Users in New York City
Source: Journal of Urban Health, March 2004, Vol. 81(1):20-4
Abstract
Poor Validity of Self-Reported Hepatitis B Virus Infection and Vaccination Status Among Young Drug Users
Source: Clinical Infectious Diseases, February 15, 2004, Vol. 38(4):587-590
Abstract
Hepatitis B Virus Infection and Vaccination Among Young Injection and Non-Injection Drug Users: Missed Opportunities to Prevent Infection
Source: Drug & Alcohol Dependence, January 7, 2004, Vol. 73(1):69-78
Abstract
The Massachusetts HIV, Hepatitis, Addiction Services Integration (HHASI) Experience: Responding to the Comprehensive Needs of Individuals with Co-Occurring Risks and Conditions
Source: Public Health Reports, January/February 2004, Vol. 119(1):25-31
HTML
Harm Reduction Archive back to top
Harm reduction journal articles 2003-2000
Immunization Action Coalition  |  1573 Selby Avenue  |  St. Paul MN 55104
contact: admin@immunize.org  |  www.immunize.org
tel: 651.647.9009  |  fax: 651.647.9131